SCHEMBL17187697

SCHEMBL17187697

CC(C)(C)Oc1nc(O)nc(OC(C)(C)C)n1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820019 0.86 GAA (0.48) GAA
SCHEMBL23964494 0.76 GAA (0.42) GAA
SCHEMBL329816 0.69 LMNA (0.35)
SCHEMBL10665040 0.68 ALDH1A1 (0.42) GAA
SCHEMBL6026795 0.68 GAA (0.41) GAA
SCHEMBL18802249 0.65
SCHEMBL14298979 0.64 L3MBTL1 (0.48) GAA
SCHEMBL632491 0.63 MEN1 (0.43) GAA
SCHEMBL147817 0.63
SCHEMBL4636238 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3131910-A1 USE OF A L,3J5-TRIAZIN-2-YL PHOSPHORAMIDATE COMPOUND IN THE SYNTHESIS OF SOFOSBUVIR Zentiva K.S. (CZ) 2017-02-22 EP disclosed
WO-2015158317-A1 USE OF A L,3J5-TRIAZIN-2-YL PHOSPHORAMIDATE COMPOUND IN THE SYNTHESIS OF SOFOSBUVIR ZENTIVA, K.S. (CZ) 2015-10-22 WO disclosed
WO-2015158317-A1 USE OF A L,3J5-TRIAZIN-2-YL PHOSPHORAMIDATE COMPOUND IN THE SYNTHESIS OF SOFOSBUVIR ZENTIVA, K.S. (CZ) 2015-10-22 WO disclosed